Factors influencing the variation in GMS prescribing expenditure in Ireland

Health Economics Review

Table 2 Percentage of GMS Claimants & Expenditure Euro million (€m) by ATC group and Age Category (2012)

Age Cohort	N		C		A		R		Total (€m)	Total GMS
Age Cohort	%	(€m)	%	(€m)	%	(€m)	%	(€m)	N,C,A,R	Cost (€m)
<5	16	0.57	2	0.35	32	0.88	51	2.01	3.81	12.35
5–11	10	1.78	2	0.29	24	1.13	64	4.33	7.53	9.46
12–15	28	1.87	2	0.11	20	0.97	50	2.15	5.10	4.76
16–24	40	9.32	5	0.52	25	3.44	31	3.91	17.20	17.12
25–34	42	27.11	8	1.80	26	7.29	24	5.32	41.52	23.69
35–44	39	39.83	13	6.83	26	12.39	22	7.62	66.68	28.19
45–54	34	46.03	21	19.31	26	19.79	19	11.32	96.45	35.65
55–64	29	46.33	27	40.68	26	29.53	18	18.56	135.11	55.41
65–69	26	23.58	30	31.59	26	19.27	17	13.06	87.49	37.30
70–74	26	27.10	32	43.61	26	23.28	16	15.22	109.21	51.13
>75	27	79.32	30	93.97	27	54.78	16	31.85	259.92	119.79
% of Total	36	302.85	29	239.06	21	172.76	14	115.34	830.01	394.86

N Nervous System, C Cardiovascular System, A Alimentary Tract & Metabolism, R Respiratory System
The most expensive age category by ATC group is highlighted in bold

ISSN: 2191-1991